| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 100,247 | 104,354 | 106,054 | 148,808 | | Cost of Revenue | 82,426 | 90,859 | 89,762 | 119,918 | | | Gross Profit | 17,821 | 13,495 | 16,292 | 28,890 | | | Operating Expenses | | Research Development | 466 | 503 | 524 | 530 | | Selling General and Administrative | 15,384 | 14,595 | 16,547 | 22,933 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,971 | (1,603) | (779) | 5,427 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 509 | 1,282 | 1,540 | 2,746 | | Earnings Before Interest And Taxes | 2,480 | (321) | 761 | 8,173 | | Interest Expense | 7,231 | 2,355 | 2,421 | 2,611 | | Income Before Tax | (4,751) | (2,676) | (1,660) | 5,562 | | Income Tax Expense | 3,901 | (2,801) | (201) | 1,969 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,652) | 125 | (1,459) | 3,593 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,652) | 125 | (1,459) | 3,593 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,652) | $125 | ($1,459) | $3,593 |
|
1.22% Nasdaq 
Income Statement
